Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer’s disease.
Saved in:
| Title: | Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer’s disease. |
|---|---|
| Authors: | Roby, Deborah A.1, Ruiz, Fernanda1, Kermath, Bailey A.1, Voorhees, Jaymie R.2, Niehoff, Michael3, Zhang, Jinsong1, Morley, John E.3, Musiek, Erik S.4, Farr, Susan A.1,3 Susan.farr@health.slu.edu, Burris, Thomas P.2 burristhomas@wustl.edu |
| Source: | PLoS ONE. 4/12/2019, Vol. 14 Issue 4, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0215004 |
